Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Long-Term Debt Repayments (2016 - 2025)

Marimed (MRMD) has disclosed Long-Term Debt Repayments for 8 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Long-Term Debt Repayments changed N/A to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.1 million through Dec 2025, changed N/A year-over-year, with the annual reading at $6.1 million for FY2025, N/A changed from the prior year.
  • Long-Term Debt Repayments for Q4 2025 was $1.5 million at Marimed, roughly flat from $1.5 million in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $15.3 million in Q2 2021, with the low at $2294.0 in Q3 2021.
  • Average Long-Term Debt Repayments over 3 years is $3.1 million, with a median of $1.5 million recorded in 2025.
  • Peak annual rise in Long-Term Debt Repayments hit 2086.0% in 2021, while the deepest fall reached 99.54% in 2021.
  • Over 3 years, Long-Term Debt Repayments stood at $619727.0 in 2021, then surged by 787.97% to $5.5 million in 2023, then crashed by 72.74% to $1.5 million in 2025.
  • According to Business Quant data, Long-Term Debt Repayments over the past three periods came in at $1.5 million, $1.5 million, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.